Celltrion Inc (068270)

सीओल
142,500
0(0.00%)
  • वॉल्यूम:
    536,289
  • बोली/पुछे:
    142,500/143,000
  • दिन की रेंज:
    142,000 - 145,000

068270 समीक्षा

पिछला बंद
142,500
दिन की रेंज
142,000-145,000
आय
2.01T
खुला
142,500
52 सप्ताह रेंज
141,000-294,608
ईपीएस
3,583.47
वॉल्यूम
536,289
मार्केट कैप
19.79T
लाभांश (यील्ड)
750.00
(0.52%)
औसत वॉल्यूम (3एम)
220,851
पी/ई अनुपात
39.77
बीटा
1.07
1- वर्ष बदलाव
-45.69%
बकाया शेयर
138,896,775
अगली कमाई तिथि
11 अग॰ 2022
Celltrion पर आपकी भावना क्या है?
या
अभी बाज़ार बंद हैं। वोटिंग बाजार का समय के दौरान खुली है।

Celltrion Inc कंपनी प्रोफाइल

Celltrion Inc कंपनी प्रोफाइल

कर्मचारी
2034

Celltrion, Inc., together with its subsidiaries, develops and produces therapeutics based on proteins including oncology treatment drugs in South Korea. The company markets Remsima, Truxima, and Herzuma products; generic pharmaceuticals; covid-19 test kits. Its antibody biosimilar pipeline includes CT-P39 for the treatment of asthma and urticaria that is in phase 1 clinical trial; CT-P17 for the treatment of rheumatoid arthritis, psoriatic arthritis, and IBD, which is in phase 3 clinical trial; CT-P16 for the treatment of metastatic colorectal cancer and breast cancer that is in phase 3 clinical trial; CT-P41 for the treatment of osteoporosis and bone loss, which is in phase 1 clinical trial; CT-P43 for the treatment of psoriasis, crohn's disease, and ulcerative colitis that is in phase 3 clinical trial; CT-P42 for the treatment of diabetic macular edema, which is in phase 3 clinical trial; CT-P27 for the treatment of pandemic/seasonal influenza that is in phase 2 clinical trial; CT-P59 for the treatment of COVID-19, which is in phase 3 clinical trial; and CT-G20 for the treatment of Cardiomyopathy that is in phase 1 clinical trial. Celltrion, Inc. has a partnership with Inhalon Biopharma, Inc. to develop IN-006, an inhaled form of regdanvimab for treating patients with COVID-19. The company was founded in 2002 and is headquartered in Incheon, South Korea.

और पढ़ें

तकनीकी सारांश

प्रकार
5 मिनट
15 मिनट
प्रति घंटा
दैनिक
मासिक
मूविंग एवरेजमजबूत विक्रयमजबूत विक्रयमजबूत विक्रयमजबूत विक्रयमजबूत विक्रय
तकनीकी संकेतकमजबूत विक्रयमजबूत विक्रयखरीदेंमजबूत विक्रयमजबूत विक्रय
सारांशमजबूत विक्रयमजबूत विक्रयतटस्थमजबूत विक्रयमजबूत विक्रय